Rheumatology Advance Access published online on April 27, 2004
Rheumatology, doi:10.1093/rheumatology/keh198
Rheumatology © British Society for Rheumatology 2004; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Rheumatology, Nuffield Orthopaedic Centre, Oxford, UK
* To whom correspondence should be addressed. E-mail: lyn.williamson{at}smnhst.swest.nhs.uk.
Objectives. To examine the relationship between the severity of nail disease and characteristics of psoriatic arthritis (PsA). We also wished to assess the clinical management of nail disease in patients with PsA. Methods. We studied 69 patients with PsA at two visits. On the first visit, a rheumatology assessment of joint, skin and nail disease was made. On the second visit, a detailed dermatology assessment of skin and nails was made. Nail disease was analysed using a 20-nail psoriasis nail severity score (PNSS). Results. There were 57 (83%) patients with clinical evidence of psoriatic nail disease. Although 66 (96%) patients had been treated for skin disease, only one (1%) had received any treatment for nail disease. Severe nail disease measured by the PNSS correlated with severe skin psoriasis as indicated by the percentage of body surface area affected by psoriasis (r = 0.34, P = 0.004) and physician global assessment of psoriasis (r = 0.45, P<0.001). Patients with distal interphalangeal (DIP) joint disease had higher PNSS scores (P = 0.03). The PNSS was also associated with unremitting and progressive arthritis (P<0.001), and correlated with Stanford health assessment questionnaire (HAQ) (r = 0.34, P = 0.004), depression (r = 0.39, P<0.001) and anxiety (r = 0.34, P = 0.004) scores. Compared with dermatology assessment, the rheumatology examination of nail disease had a positive predictive value of 84% and negative predictive value of 83%. Conclusions. In patients with PsA, the severity of nail disease correlates with indicators of severity of both skin and joint disease. Although rheumatologists can adequately screen for nail disease, the management of this aspect of PsA is often overlooked. KEY WORDS:
Key words: Psoriatic arthritis, Nail disease.
Accepted March 17, 2004
Original Papers
Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked
2 Department of Dermatology, Churchill Hospital, Oxford, UK
3 ICRF/NHS Centre for Statistics in Medicine, Institute of Health Sciences, Oxford, UK
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in Rheumatology:
- Skin and bones---mind the gap
- L. Robertson and D. de Berker
Rheumatology 2004 10.1093/rheumatology/keh207.[PDF]
This article has been cited by other articles:
|
|
 |
|
  A. L. Tan, M. Benjamin, H. Toumi, A. J. Grainger, S. F. Tanner, P. Emery, and D. McGonagle The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis--a high-resolution MRI and histological study Rheumatology, February 1, 2007; 46(2): 253 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kyle, D. Chandler, C. E. M. Griffiths, P. Helliwell, J. Lewis, I. McInnes, S. Oliver, D. Symmons, N. McHugh, and on behalf of the British Society for Rheumatology Guideline for anti-TNF-{alpha} therapy in psoriatic arthritis Rheumatology, March 1, 2005; 44(3): 390 - 397. [Full Text] [PDF]
|
|